All posts by: Michael Zand

About Michael Zand

Chinese Doctors Are Using Modified T-Cells to Treat Advanced Forms of Cancer – Futurism

Continue reading

2018-02-21 NEWS

Chinese Doctors Are Using Modified TCells to Treat Advanced Forms of Cancer
Futurism
But, as is also true of other forms of cancer, chemotherapy isn’t always successful. In China, and around the world, there’s a great need for the development of new treatments. Dr. Shixiu Wu, president of the Hangzhou Cancer Hospital, has tested a

and more »

Continue reading

2018-02-21 NEWS

hcanews.com

Lost in the CRISPR Hype, a Gene-Editing Giant Is Fighting Back
hcanews.com
… Sangamo have slowly been stocking freezers at their Bay Area headquarters with pairs of zinc fingers, the proteins that regulate gene expression. At one point, their technology was considered the cutting edge of genomic medicine, and Sangamo’s

Continue reading

2018-02-21 NEWS

Philadelphia Business Journal

The partnership ushered in a new era of oncological care
Philadelphia Business Journal
Novartis wasn’t sure where it was going to go.” CART Cell therapy is a process that begins by drawing blood from a patient and separating out the T cells, which direct the body’s immune response for killing cells infected by pathogens. The T cells are

Continue reading

2018-02-21 NEWS

ICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit
AJMC.com Managed Markets Network
CAR T-cell therapy has emerged as a novel way to treat cancer, genetically reprogramming a patient’s own white blood cells to attack tumor cells, and was recently named the American Society of Clinical Oncology’s Advance of the Year. Earlier this month